Billy Wilson Nyambalo

Billy Wilson Nyambalo

Auto-generated profile, based on publicly available information

Billy Wilson Nyambalo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
MCMaster R.O. Chisale
Master R.O. Chisale
FSFrank Watson Sinyiza
Frank Watson Sinyiza
PKPaul Uchizi Kaseka
Paul Uchizi Kaseka
CCChikondi Sharon Chimbatata
Chikondi Sharon Chimbatata
BMBalwani Chingatichifwe Mbakaya
Balwani Chingatichifwe Mbakaya
AKAlfred Bornwell Kayira
Alfred Bornwell Kayira
As the fight against the COVID-19 pandemic continues, reports indicate that the global vaccination rate is still far below the target. Understanding the levels of reinfection may help refocus and inform policymakers on vaccination. This retrospective study in Malawi included individuals and patients who tested for COVID-19 infections via reverse transcriptase polymerase chain reaction (rt-PCR) from the data at the Public Health Institute of Malawi (PHIM). We included all data in the national line list from April 2020 to March 2022. Upon review of 47,032 records, 45,486 were included with a reported 82 (0.18) reinfection representing a rate of 0.55 (95% CI: 0.44–0.68) per 100,000 person-days of follow-up. Most reinfections occurred in the first 90 to 200 days following the initial infection, and the median time to reinfection was 175 days (IQR: 150–314), with a range of 90–563 days. The risk of reinfection was highest in the immediate 3 to 6 months following the initial infection and declined substantially after that, and age demonstrated a significant association with reinfection. Estimating the burden of SARS-CoV-2 reinfections, a specific endurance of the immunity naturally gained, and the role played by risk factors in reinfections is relevant for identifying strategies to prioritise vaccination.

20 February 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
MCMaster R.O. Chisale
Master R.O. Chisale
DKDzinkambani Kambalame
Dzinkambani Kambalame
SMSAUL ERIC MWALE
SAUL ERIC MWALE
BMBalwani Chingatichifwe Mbakaya
Balwani Chingatichifwe Mbakaya
RMRegina Mankhamba
Regina Mankhamba
EBEvelyn Chitsa Banda
Evelyn Chitsa Banda
Vaccination is one of the essential measures in reducing transmission, morbidity, and mortality rates of a disease. However, the COVID-19 vaccination is facing hesitancy across the globe, Malawi included. A population-based cross-sectional study was conducted in Malawi to document knowledge, attitudes, and practices on COVID-19 vaccination. The study targeted the general adult population and employed a multi-stage sampling technique. The Census Enumeration Areas within the 16 selected districts served as a primary sampling unit. Among the total 3068 participants, 1947 (63.6%) were female. About 1039 (34.1%) participants had primary education, while only 169 (5.5%) had college education. A total of 2936 (95.7%) participants knew about the COVID-19 vaccine, and 2063 (68.4%) felt that the COVID-19 vaccine was effective. A total of 1180 (38.7%) got vaccinated. Knowledge of the COVID-19 vaccination was significantly associated with participants’ education levels, location, occupation, marital status, household family income, and whether they were suffering from chronic illness or not. Overall, the level of knowledge and attitudes about the COVID-19 vaccination was good. This study has also established that different population groups have statistically different levels of knowledge and attitudes regarding COVID-19 vaccination. This study has also indicated a significant relationship between the rate of vaccination and several factors. Therefore, this calls for stakeholders to continue awareness and group-targeted tailored campaigns so as to increase COVID-19 vaccination.